Your browser doesn't support javascript.
loading
Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis.
Makunts, Tigran; Cohen, Isaac V; Awdishu, Linda; Abagyan, Ruben.
Afiliación
  • Makunts T; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093-0747, USA.
  • Cohen IV; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093-0747, USA.
  • Awdishu L; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093-0747, USA.
  • Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, 92093-0747, USA. ruben@ucsd.edu.
Sci Rep ; 9(1): 2282, 2019 02 19.
Article en En | MEDLINE | ID: mdl-30783195

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Equilibrio Hidroelectrolítico / Nefrolitiasis / Inhibidores de la Bomba de Protones / Lesión Renal Aguda Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Equilibrio Hidroelectrolítico / Nefrolitiasis / Inhibidores de la Bomba de Protones / Lesión Renal Aguda Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos